How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic?

Acta Haematol (2021) 144 (5): 500–507.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Hematopoietic Stem Cell Transplantation Activity in China 2020–2021 During the SARS-CoV-2 Pandemic: A Report From the Chinese Blood and Marrow Transplantation Registry Group

Lan-Ping Xu
Dao-Pei Lu
De-Pei Wu
Er-Lie Jiang
Dai-Hong Liu
He Huang
Zi-Min Sun
Nai-Nong Li
Qi-Fa Liu
Xi Zhang
Yong-Rong Lai
Yong-Ping Song
Xian-Min Song
Si-Xi Liu
Yi-Cheng Zhang
Cheng-Juan Luo
Ling-Hui Xia
Ting Niu
Yu Yu
Xiao-Hui Zhang
Xiao-Wen Tang
Yi Luo
Xiao-Jun Huang

Transplantation and Cellular Therapy (2023) 29 (2): 136.e1.

Changes in the medical-seeking pattern and daily behavior of hematopoietic stem-cell transplant recipients during the COVID-19 epidemic: An online survey in Hubei Province, China

Rong Xie
Yicheng Zhang
Zhiping Huang
Si Cheng
Jingming Guo
Youshan Zhang
Min Liu
Xiaojian Zhu
Yong You
Ping Zou
Wenlan Chen
Han Yan
Fanjun Cheng
Zhaodong Zhong

Frontiers in Public Health (2022) 10

Is there a role for haematopoietic cell transplants after radiation and nuclear accidents?

Robert Peter Gale

Journal of Radiological Protection (2021) 41 (2): R43.

Mélange intéressante: COVID-19, autologous transplants and multiple sclerosis

Juan Carlos Olivares Gazca
David Gómez Almaguer
Robert Peter Gale
Guillermo José Ruiz Argüelles

Hematology (2020) 25 (1): 320.